Dust is rubbish, literally. And in a pharmaceutical plant it can also put employee health in danger and be the cause of product recalls.
Most drugmakers have systems in place to remove dust from capsule filling lines, but such technologies take up space and reduce the available manufacturing area, which is a problem given that production capacity is king in the pharmaceutical industry.
To help address the problem New Jersey, US-based Pharma Technology Inc (PTI) has launched a new range of vertical combined de-dusting and polishing systems capable of cleaning up to 500,000 drug capsules per hour.
PTI claims that each of the PTG-V line’s three models are fully mobile, offer quick tool-free dismantling and reassembly, and occupy minimal floor space. In addition, it says each system can be dismounted without tooling, and cleaned via ultrasonic wave bath.
Spokesman Nic Michel added that: “The PTG-V Vertical Capsules Dedusters are fast, accurate, easy to operate and clean, and adaptable to important ancillary priorities such as metal detection and empty capsule elimination.
“When the line’s compactness and cost-effectiveness also are considered, the PTG-V series compares favorably to all other dedusting sector competitors.”
Dusty pharmaceutical plants are also a problem for Australian drugmakers according to Eximo, which claims to be the country’s leading ducting supplier.
The New South Wales firm set the problem in the context of the growth of Australia’s drug manufacturing industry, which it said has already overtaken vehicle and textile production and is on track to become the second biggest sector behind mining.
All of which means more dusty drug plants according to Eximo, which said that: “Given the healthy growth of the sector, and to ensure that the nation’s leading drug makers continue to achieve export success.
The firm added that: “it is important to maintain the reputation of the industry as a producer of pure, reliable and high quality products by facilitating a clean and sterile work environment.”
Luckily, such concerns have also created a bit of an opportunity for Eximo, which believes that its ability to make ventilation ducting that resists temperatures of up to 300°C, is impervious to microbes and hydrolysis can help drugmakers with their dust difficulties.